These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2030102)

  • 1. The changing horizon in the treatment of depression: scientific/clinical publication overview.
    Stokes PE
    J Clin Psychiatry; 1991 May; 52 Suppl():35-43. PubMed ID: 2030102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting depression and anxiety: special diagnostic and treatment issues.
    Lydiard RB
    J Clin Psychiatry; 1991 Jun; 52 Suppl():48-54. PubMed ID: 2050649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontricyclic antidepressants: current trends in children and adolescents.
    Emslie GJ; Walkup JT; Pliszka SR; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):517-28. PubMed ID: 10230183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine in the treatment of panic disorder and its complications.
    Liebowitz MR
    Psychiatr Clin North Am; 1985 Mar; 8(1):37-47. PubMed ID: 3887338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
    Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J
    J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the long-term treatment of depression.
    Hirschfeld RM
    J Clin Psychiatry; 1994 Dec; 55 Suppl():61-9; discussion 70-1. PubMed ID: 7814359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drug treatment of panic disorder.
    Matuzas W; Jack E
    Psychiatr Med; 1991; 9(2):215-43. PubMed ID: 1677479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New indications for antidepressants.
    Schatzberg AF
    J Clin Psychiatry; 2000; 61 Suppl 11():9-17. PubMed ID: 10926050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.